Feussner, G.

Apolipoprotein E2 (Arg-136-->Cys), a variant of apolipoprotein E associated with late-onset dominance of type III hyperlipoproteinaemia

FEUSSNER, G., ALBANESE, M., MANN, W. A., VALENCIA, A., & SCHUSTER, H. (1996) · European Journal of Clinical Investigation

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 29

Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and & epsilon;1/lsquo;null genotype‡

FEUSSNER, G., FUNKE, H., WENG, W., ASSMANN, G., LACKNER, K. J., & ZIEGLER, R. (1992) · European Journal of Clinical Investigation

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 28

Clinical features of type III hyperlipoproteinemia: analysis of 64 patients

Feussner, G., Wagner, A., Kohl, B., & Ziegler, R. (1993) · The Clinical Investigator

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 27

Apolipoprotein E5 (Glu212–>Lys): increased binding to cell surface proteoglycans but decreased uptake and lysosomal degradation in cultured fibroblasts.

Feussner, G., Scharnagl, H., Scherbaum, C., Acar, J., Dobmeyer, J., Lohrmann, J., Wieland, H., & März, W. (1996) · Journal of Lipid Research

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 21

Severe xanthomatosis associated with familial apolipoprotein E deficiency.

Feussner, G. (1996) · Journal of Clinical Pathology

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 10

Three-dimensional structure of the LDL receptor-binding domain of the human apolipoprotein E2 (Arg136 → Cys) variant

Feussner, G., Albanese, M., & Valencia, A. (1996) · Atherosclerosis

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 7

A 10 BP deletion in the apolipoprotein ε gene causing apolipoprotein E deficiency and severe type III hyperlipoproteinemia

Feussner, G., Dobmeyer, J., Lohmer, S., & Wohlfeil, S. (1995) · Atherosclerosis

Lipoproteins and Cardiovascular HealthLipid metabolism and disorders

Cited by 4

Response to therapy of a type III hyperlipoproteinemic subject with the rare apolipoprotein E1 (Gly127 ? Asp, Arg158 ? Cys) variant

Feussner, G., & Ziegler, R. (1992) · The Clinical Investigator

Lipid metabolism and disordersLipoproteins and Cardiovascular Health

Cited by 3